CYBERnano is a key member of the TBMED project in which the company is developing new statistical methods and tools to facilitate the implementation of Quality-by-Design services for SME in Medical Device Engineering: https://tbmed.eu/quality-by-design
TBMED aims to develop an Open Innovation Test Bed (OITB) for high risk medical devices that provides a single entry point to services along the whole value chain from preclinical development to clinical testing. The entire development will be based on a Quality-by-Design (QbD) concept.
TBMED aims to support med-tech companies in the development of high-risk medical devices by reducing their time-to-market for the European sector.
TBMED will help European SMEs to maintain their competitiveness and innovation capacity in the face of global competition, e.g. from larger providers. Its aim is to minimize time-to-market and efforts for reimbursement and make medical devices accessible to patients more easily.
In the TBMED project UNIZAR is represented by the Bionanosurf group, a pluridisciplinary laboratory carrying out research in the fields of nanoscience, nanomaterials and nanomedicine. Bionanosurf belongs to the Institute of Materials Science of Aragón (ICMA), a Joint Research Unit established by the Spanish National Research Council (CSIC) and the University of Zaragoza.
In TBMED UNIZAR is the leader of Work Package 6. This includes the synthesis and characterization of inorganic (magnetic, gold, etc.) nanoparticles, advanced microscopy techniques and preclinical testing. In addition, UNIZAR will be involved in the development of one of the medical devices (magnetic nanoparticles for hyperthermia), as well as in the Open Innovation test bed establishment.